Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Correlation between fatigue and quality of life in patients with hematological malignancies treated with biosimilar epoetin alfa (Sandoz) for chemotherapy induced anemia

Trial Profile

Correlation between fatigue and quality of life in patients with hematological malignancies treated with biosimilar epoetin alfa (Sandoz) for chemotherapy induced anemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Epoetin alfa (Primary)
  • Indications Chemotherapy-induced anaemia
  • Focus Therapeutic Use
  • Acronyms the Ciroco Study
  • Most Recent Events

    • 22 Jul 2018 New trial record
    • 17 Jun 2018 Results (n=104) presented at the 23rd Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top